TD Cowen analyst Ritu Baral has maintained their bullish stance on SGMO stock, giving a Buy rating yesterday. Ritu Baral has given her Buy ...

The Oxford district's insurance company had argued its liability for the entire attack should be capped at $5 million.

Dr. Quezada-Ruiz was most recently Group Medical Director, Ophthalmology at Genentech, where he led clinical development and approval of VABYSMO and SUSVIMO ...

Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain, spinal cord, and optic nerves. Continuous research has led to new drug ...

This transcript has been edited for clarity. Kathy D. Miller, MD: Hi. I'm Kathy Miller, Professor of Medicine at the IU School of Medicine and Joining me today is Dr Richard Zellars, the Chair of the ...

The cell therapy biotech had been buoyed by a $3 billion biobucks partnership with Genentech, a deal the Roche subsidiary ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

Good afternoon and welcome to the Sangamo Therapeutics Third Quarter 2024 Teleconference Call. Please be advised that today's conference is being recorded. I would now like to turn the conference over ...

"Dr. Mora's extensive experience in immunology and nanoparticles establishes a strong foundation for our new immune programs and our ongoing collaboration with Genentech," said Kunwoo Lee, Ph.D., ...

Dr. Alexander brings two decades of biotechnology, biopharma, and medical leadership, most recently as SVP, Research & Development and Head of Boston Roche Innovation Center (BRIC), for ...

BioNTech has established a broad set of relationships with multiple global and specialized pharmaceutical collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche ...